宾夕法尼亚大学头颈癌服务线COVID-19管理指南
该指南由宾夕法尼亚大学多医院三级医疗系统内头颈癌管理相关从业者共识制定,旨在COVID-19大流行期间为头颈癌的合理管理提供方向,以在医学和伦理上取得风险与获益的适当平衡。共识声明支持在疫情期间采用符合当地诊疗标准及头颈肿瘤学文献的伦理方法管理头颈癌。
要点
- 多学科共识支持疫情期间头颈癌管理的伦理决策。
- 管理策略需平衡医学风险与获益,并符合当地标准。
- 指南适用于多医院三级医疗系统的头颈癌服务线。
核心结论
- 该共识指南支持在COVID-19疫情期间采用伦理方法管理头颈癌,与当地诊疗标准及头颈肿瘤学文献一致。
研究设计与样本
- 通过共识制定过程,在广泛参与头颈癌管理的从业者中形成共识声明,涉及多医院三级医疗系统。
主要发现
- 共识过程产生了涉及头颈癌管理多方面从业者的共识声明。
临床怎么用
- 在疫情期间,头颈癌管理应参考该共识声明,以在医学和伦理上平衡风险与获益。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: The COVID-19 pandemic caused by the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) virus has altered the health care environment for the management of head and neck cancers. The purpose of these guidelines is to provide direction during the pandemic for rational Head and Neck Cancer management in order to achieve a medically and ethically appropriate balance of risks and benefits. METHODS: Creation of consensus document. RESULTS: The process yielded a consensus statement among a wide range of practitioners involved in the management of patients with head and neck cancer in a multihospital tertiary care health system. CONCLUSIONS: These guidelines support an ethical approach for the management of head and neck cancers during the COVID-19 epidemic consistent with both the local standard of care as well as the head and neck oncological literature.
引用
- Weinstein GS, Cohen R, Lin A, et al. Penn Medicine Head and Neck Cancer Service Line COVID-19 management guidelines. Head Neck. 2020. PMID: 32584447. doi:10.1002/hed.26318
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。